Clinical Trial

Human Skin Safety Testing of 1 Mitopure Topical Product Using a Clinical Safety in Use Study in Healthy Volunteers

Study acronym: SIU-1
Completed
View on ClinicalTrials.gov →
Summary
The objective of this study is to investigate the safety of 1 topically applied test article containing Mitopure in a panel of healthy volunteers.
Protocol Amendment History 5 changes
critical Trial completed 2026-06-12
notable Enrollment increased: 30 -> 40 participants 2026-06-12
notable Primary completion moved earlier: 2026-09-15 -> 2026-05-04 2026-06-12
minor Completion moved earlier: 2026-09-15 -> 2026-05-04 2026-06-12
critical Recruitment opened 2026-05-29
Trial Details
NCT Number NCT07517900
Lead Sponsor Amazentis SA
Collaborators: Princeton Consumer Research
Conditions Healthy Adult
Enrollment 40 participants
Start Date 2026-04-20
Primary Completion 2026-05-04 (estimated)
Study Completion 2026-05-04 (estimated)
Updated on ClinicalTrials.gov 2026-06-11